Omeros' IND application for OMS721 in thrombotic microangiopathies gets US ... pharmabiz.com ... phase 2 clinical trial, planned to begin later this quarter, will evaluate the effects of the drug on patients with TMAs, including atypical hemolytic uremic syndrome (aHUS), thrombotic thrombocytopenic purpura (TTP), and stem cell transplant ... |
